Phong Phu Pharmaceutical JSC (HNX:PPP)
18,100
-900 (-4.74%)
At close: Jan 30, 2026
HNX:PPP Revenue
Phong Phu Pharmaceutical JSC had revenue of 32.51B VND in the quarter ending September 30, 2025, a decrease of -11.86%. This brings the company's revenue in the last twelve months to 134.98B, down -2.84% year-over-year. In the year 2024, Phong Phu Pharmaceutical JSC had annual revenue of 137.55B, down -9.61%.
Revenue (ttm)
134.98B
Revenue Growth
-2.84%
P/S Ratio
1.25
Revenue / Employee
636.71M
Employees
212
Market Cap
168.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 137.55B | -14.62B | -9.61% |
| Jan 1, 2024 | 152.17B | 1.60B | 1.06% |
| Dec 31, 2022 | 150.57B | 17.29B | 12.97% |
| Dec 31, 2021 | 133.29B | 17.03B | 14.65% |
| Dec 31, 2020 | 116.26B | -35.27B | -23.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Domesco Medical Import - Export Joint-Stock | 2.08T |
| Vimedimex Medi-Pharma JSC | 1.17T |
| OPC Pharmaceutical JSC | 1.06T |
| Vidipha Central Pharmaceutical JSC | 950.89B |
| Ben Tre Pharmaceutical JSC | 839.79B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Central Pharmaceutical Joint Stock Company No3 | 438.01B |
| Mediplantex National Pharmaceutical JSC | 367.08B |